ADVANTIS CORPORATI COM USD0.0001 (OTCMKTS:ADVT) is a penny play in the cannabis patch that has recently popped onto the radar of the MJ OTC crowd, launching ADVT from the deep sub-penny ranks to nearly 2 cents per share in just the past few weeks. The key narrative is around recreational marijuana sales and packaging solutions, but the devil is in the details and this is actually a more complicated story than it may at first appear. The company’s most recent key catalyst is around becoming a fully-reporting firm.
From what we can see, the company’s main “sticky” product, from a branding perspective, is its “Amstercan” sales and packaging solution. However, it appears to us that this is not the company’s product, and they are buying each unit from another company and then marketing them without necessarily any clear route to profitability. For example, you can go to the store and buy candy bars and then sell them to someone else at the same price, and you start generating serious revenues, but it doesn’t mean you’re a successful business. The details of the nature of the partnerships that drive these sales is going to ultimately tell us whether this one is a pretender or contender. For now, the jury is still out. That said, we require only additional clarity and we may well love this stock. It’s certainly worth a look.
ADVANTIS CORPORATI COM USD0.0001 (OTCMKTS:ADVT) trumpets itself as a company focused on helping people take control of their health and pain management needs. By creating strategic partnerships with innovative companies in the nutraceutical and alternative health care industries, Advantis is uniquely positioned to provide the guidance and support to assist in delivering products and services that address the needs of these individuals.
Acquiring ownership in developing companies allows Advantis to provide consultation to improve product lines, expand distribution channels, and heighten brand value.
With the healthcare and pain management sectors forecasting staggering growth, Advantis identifies and partners with those companies that possess the potential to capitalize on this trend.
One of the company’s key solutions relies on nitrogen packaging: “Our packaging system provides a unique patented process of canning organically cultivated cannabis which hermetically seals and preserves the contents. Hermetic sealing is a process of utilizing nitrogen to replace air and moisture, thereby dramatically extending the product’s shelf life while preserving cellular integrity and sealing in the product’s natural odors. Our patented system is ideal for products with high sensitivities such as pharmaceuticals and cannabis, and preserves your product’s freshness for up to 5 years.”
Find out when $ADVT stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, the company just announced that it is taking steps to become a fully-reporting public company. The rate at which Advantis has been growing revenue and acquiring new shareholders is cited as the reason for the decision. An SEC fully-reporting company is one that must adhere to more stringent SEC reporting guidelines that are designed to increase transparency for investors.
According to the release, Advantis began growing their revenue when they launched the Amstercan packaging solution late last year. Revenue increased dramatically a month later, when Advantis added rosin presses to its product lineup. “It has always been our goal to become a leader in the cannabis space,” said Advantis CEO, Christopher Swartz, “and now that we are generating significant ongoing revenue, becoming a fully-reporting company is the next logical step.”
At this point, this company is more mystery than analyzable quantity. The language used in press releases seems extremely strategic and oblique, with references to their pot and their packaging solutions, but all couched in a framework of strategic partnerships and a lack of obvious in-house resources. This may well be a serious winner, but we are going to remain cautious and keep an eye out for something meatier to comb through so we can understand the nature of this beast a bit better before committing to a view.
The chart shows nearly 360% tacked on to share pricing for the company in the past month. The situation may be worth watching. ADVT is a stock who’s past is littered with sudden rips. Moreover, the listing has witnessed a pop in interest, as transaction volume levels have recently pushed approaching 230% over the long run average.
At this time, carrying a capital value in the market of $18.1M, ADVT has virtually no cash on the books, which is balanced by about a half million bucks in total current liabilities, as far as we can see. Advantis is not generating any material revenues over reported periods, but recent press suggests that some kind of announcement is imminent that alters this view. You can bet we will update this one again as new information comes into view. For continuing coverage on shares of $ADVT stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!
